Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrea Logreco"'
Autor:
Caterina Di Fabio, Felice Simiele, Nicola Petragnani, Nicola Tinari, Piergustavo De Francesco, Michele Marchioni, Luca Cindolo, Andrea Logreco, Luigi Schips, Michele De Tursi
Publikováno v:
Minerva Urologica e Nefrologica. 72
Background The aim of this study was to assess adherence to and persistence with androgen deprivation therapy (ADT) in a large cohort of prostate cancer (PCa) patients selected from an administrative database, with special attention to elderly patien
Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials
Autor:
Alessia Romagnoli, Fiorenzo Santoleri, Ruggero Lasala, Andrea Logreco, Alberto Costantini, Felice Musicco
Publikováno v:
European journal of clinical pharmacology. 76(6)
The European Medicine Agency (EMA) authorizes the marketing of drugs, with the authorization being full, conditional or issued under exceptional circumstances. Usually the efficacy and safety of drugs must be demonstrated in at least 2 well-controlle
Autor:
Rosa Amoroso, Andrea Logreco, Marialuigia Fantacuzzi, Alberto Costantini, Fiorenzo Santoleri, Alessandra Ammazzalorso, Ruggero Lasala
Publikováno v:
Drugs & Therapy Perspectives. 34:263-268
Adherence is considered the key to the success of treatment with combination antiretroviral therapy (cART). In the past, people receiving cART needed to take several different pills each day (i.e., multi-tablet regimens; MTRs), with this complicated
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(5)
The aim of this study was to verify whether the distribution of a treatment diary by a pharmacist could influence the adherence to oral treatment with imatinib, nilotinib, and dasatinib in patients with chronic myeloid leukaemia.The level of adherenc
Publikováno v:
International Journal of Pharmaceutical Sciences Research. 3
The primary purpose of this study was to evaluate the medication adherence of MS patients to oral and parenteral self-administration therapy. The secondary outcome was to study how the adherence varies respect of the length of treatment and calculate